Fondens formål er at yde økonomisk støtte til videre videnskabelig forskning til læger, der beskæftiger sig særligt med forskning og helbredelse af hudsygdomme
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 9 mio. | 29.9 mio. | 326.9 mio. | 190.3 mio. | - | |
CVR: 17176811
6 properties
Upgrade to Pro to see addresses, building data and ownership details
Compared to 566 companies in Støtteaktiviteter relateret til sygdomsbekæmpende, sociale og velgørende formål
Comparison is based on industry median values
Morten Juul Heding Andersen left the board
The financial health of AAGE BANGS FOND appears strong, with significant growth in revenue and profitability over the past few years. In 2025, the company reported a revenue of 8,992,685 DKK and a profit of 29,876,515 DKK, marking a substantial increase from 4,323,918 DKK in revenue and a loss of 2,592,226 DKK in 2023. The equity position has also improved, rising to 190,262,778 DKK in 2025 from 128,397,477 DKK in 2023, indicating a solid foundation for future growth. However, the fluctuating profit margins in previous years raise some concerns about operational stability. Overall, AAGE BANGS FOND is well-positioned within its industry, focusing on support activities related to disease prevention and charitable purposes.
AI-generated summary
Companies in the same industry and area
CVR 31951860
CVR 36139323
CVR 37963704
CVR 58984728
CVR 30958217
companydata.dk